State Street’s Vyant Bio VYNT Stock Holding History
Bought
Maintained
Sold
Other funds holding VYNT
State Street's VYNT Position: Q2 2023 in Review
State Street sold out of Vyant Bio (VYNT) in Q2 2023, closing a stake of 15,038 shares — an estimated $8.72K sold.
State Street first reported a position in VYNT in Q2 2021 and held it in 8 quarters. The position peaked at $197K in Q2 2021. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- State Street reported no remaining Vyant Bio position as of Q2 2023 after selling out during the quarter.
- State Street sold 15,038 Vyant Bio shares in Q2 2023, an estimated $8.72K.
- State Street first reported a position in Vyant Bio in Q2 2021 and held it in 8 quarters.
- State Street's Vyant Bio position peaked at $197K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Vyant Bio as of Q2 2023.
Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.